SMTL ID : 5fyk.1

Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade B JR-FL SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122, 35O22 and VRC01

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.11 Å

Oligo State

hetero-3-3-3-3-3-3-6-mer

Ligands

3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 3 residues within 4Å: Chain A: P.98, N.100, S.102 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.26: 3 residues within 4Å: Chain I: P.98, N.100, S.102 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.51: 3 residues within 4Å: Chain Q: P.98, N.100, S.102 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.2: 20 residues within 4Å: Chain A: G.16, S.17 Chain B: N.30, F.31, H.33, S.52, Y.54, S.55, D.57, K.58, N.59, R.110, D.111, G.112, S.113, T.115 Chain C: H.95, N.96 Chain D: E.57, N.58 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain C Hydrogen bonds: B:D.111, B:D.111, B:G.112, B:T.115, C:H.95, B:H.33, B:S.52, B:R.110, B:D.111, C:H.95, B:D.111 NAG-NAG-BMA-MAN-MAN-MAN-MAN.27: 20 residues within 4Å: Chain I: G.16, S.17 Chain J: N.30, F.31, H.33, S.52, Y.54, S.55, D.57, K.58, N.59, R.110, D.111, G.112, S.113, T.115 Chain K: H.95, N.96 Chain L: E.57, N.58 2 PLIP interactions: 1 interactions with chain J, 1 interactions with chain K Hydrogen bonds: J:D.111, J:D.111, J:G.112, J:T.115, K:H.95, J:H.33, J:S.52, J:R.110, J:D.111, J:D.111, K:H.95 NAG-NAG-BMA-MAN-MAN-MAN-MAN.52: 20 residues within 4Å: Chain Q: G.16, S.17 Chain R: N.30, F.31, H.33, S.52, Y.54, S.55, D.57, K.58, N.59, R.110, D.111, G.112, S.113, T.115 Chain S: H.95, N.96 Chain T: E.57, N.58 2 PLIP interactions: 1 interactions with chain R, 1 interactions with chain S Hydrogen bonds: R:D.111, R:D.111, R:G.112, R:T.115, S:H.95, R:H.33, R:S.52, R:R.110, R:D.111, S:H.95, R:D.111

6 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.3: 4 residues within 4Å: Chain D: K.102, N.124, Y.141 Chain F: E.19 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.7: 16 residues within 4Å: Chain D: V.35, K.175, E.179, P.180, R.220, N.230, R.272, N.343, G.345, R.402, C.407, S.408, S.409 Chain W: Q.116, S.140 Ligands: NAG-NAG-BMA-MAN-MAN-MAN.18 3 PLIP interactions: 2 interactions with chain D, 1 interactions with chain W Hydrogen bonds: D:G.345, D:S.408, W:Q.116 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.28: 4 residues within 4Å: Chain L: K.102, N.124, Y.141 Chain N: E.19 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.32: 16 residues within 4Å: Chain G: Q.116, S.140 Chain L: V.35, K.175, E.179, P.180, R.220, N.230, R.272, N.343, G.345, R.402, C.407, S.408, S.409 Ligands: NAG-NAG-BMA-MAN-MAN-MAN.43 3 PLIP interactions: 2 interactions with chain L, 1 interactions with chain G Hydrogen bonds: L:G.345, L:S.408, G:Q.116 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.53: 4 residues within 4Å: Chain T: K.102, N.124, Y.141 Chain V: E.19 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.57: 16 residues within 4Å: Chain O: Q.116, S.140 Chain T: V.35, K.175, E.179, P.180, R.220, N.230, R.272, N.343, G.345, R.402, C.407, S.408, S.409 Ligands: NAG-NAG-BMA-MAN-MAN-MAN.68 3 PLIP interactions: 2 interactions with chain T, 1 interactions with chain O Hydrogen bonds: T:G.345, T:S.408, O:Q.116

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.4: 3 residues within 4Å: Chain D: N.128, V.137, K.139 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.29: 3 residues within 4Å: Chain L: N.128, V.137, K.139 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.54: 3 residues within 4Å: Chain T: N.128, V.137, K.139 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.5: 4 residues within 4Å: Chain D: N.155 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.15, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.15, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.15 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.30: 4 residues within 4Å: Chain L: N.155 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.55: 4 residues within 4Å: Chain T: N.155 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.65, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.65, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.65 No protein-ligand interaction detected (PLIP)

6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.6: 3 residues within 4Å: Chain D: E.53, N.197, N.209 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN.14: 9 residues within 4Å: Chain D: V.326, F.327, N.328, N.358 Chain G: Q.180, G.181, R.199 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.15, NAG-NAG.19 1 PLIP interactions: 1 interactions with chain G Hydrogen bonds: G:R.199 NAG-NAG-BMA-MAN.31: 3 residues within 4Å: Chain L: E.53, N.197, N.209 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN.39: 9 residues within 4Å: Chain L: V.326, F.327, N.328, N.358 Chain O: Q.180, G.181, R.199 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40, NAG-NAG.44 1 PLIP interactions: 1 interactions with chain O Hydrogen bonds: O:R.199 NAG-NAG-BMA-MAN.56: 3 residues within 4Å: Chain T: E.53, N.197, N.209 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN.64: 9 residues within 4Å: Chain T: V.326, F.327, N.328, N.358 Chain W: Q.180, G.181, R.199 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.65, NAG-NAG.69 1 PLIP interactions: 1 interactions with chain W Hydrogen bonds: W:R.199

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.8: 7 residues within 4Å: Chain B: V.78 Chain D: N.244 Chain H: Y.28, R.64, W.65, P.67, Y.89 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.33: 7 residues within 4Å: Chain J: V.78 Chain L: N.244 Chain P: Y.28, R.64, W.65, P.67, Y.89 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.58: 7 residues within 4Å: Chain R: V.78 Chain T: N.244 Chain X: Y.28, R.64, W.65, P.67, Y.89 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.9: 2 residues within 4Å: Chain D: E.261, N.263 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN.34: 2 residues within 4Å: Chain L: E.261, N.263 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN.59: 2 residues within 4Å: Chain T: E.261, N.263 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.10: 8 residues within 4Å: Chain D: N.269, I.290, Q.404 Chain W: G.123, G.124, G.229, P.231 Chain X: G.39 2 PLIP interactions: 2 interactions with chain W Hydrogen bonds: W:G.123, W:G.124 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.35: 8 residues within 4Å: Chain G: G.123, G.124, G.229, P.231 Chain H: G.39 Chain L: N.269, I.290, Q.404 2 PLIP interactions: 2 interactions with chain G Hydrogen bonds: G:G.123, G:G.124 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.60: 8 residues within 4Å: Chain O: G.123, G.124, G.229, P.231 Chain P: G.39 Chain T: N.269, I.290, Q.404 2 PLIP interactions: 2 interactions with chain O Hydrogen bonds: O:G.123, O:G.124

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.11: 15 residues within 4Å: Chain D: R.294, H.297, N.299, T.377 Chain E: R.103, I.104, Y.105, G.106, V.107 Chain F: S.24, N.44, N.45, P.60, G.61, S.62 2 PLIP interactions: 1 interactions with chain E, 1 interactions with chain D Hydrogen bonds: E:R.103, D:R.294 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.36: 15 residues within 4Å: Chain L: R.294, H.297, N.299, T.377 Chain M: R.103, I.104, Y.105, G.106, V.107 Chain N: S.24, N.44, N.45, P.60, G.61, S.62 2 PLIP interactions: 1 interactions with chain M, 1 interactions with chain L Hydrogen bonds: M:R.103, L:R.294 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.61: 15 residues within 4Å: Chain T: R.294, H.297, N.299, T.377 Chain U: R.103, I.104, Y.105, G.106, V.107 Chain V: S.24, N.44, N.45, P.60, G.61, S.62 2 PLIP interactions: 1 interactions with chain U, 1 interactions with chain T Hydrogen bonds: U:R.103, T:R.294

6 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.12: 2 residues within 4Å: Chain D: N.306, D.307 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.13: 4 residues within 4Å: Chain D: R.317, N.322 Ligands: NAG-NAG.17, NAG-NAG.17 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.37: 2 residues within 4Å: Chain L: N.306, D.307 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.38: 4 residues within 4Å: Chain L: R.317, N.322 Ligands: NAG-NAG.42, NAG-NAG.42 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.62: 2 residues within 4Å: Chain T: N.306, D.307 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN.63: 4 residues within 4Å: Chain T: R.317, N.322 Ligands: NAG-NAG.67, NAG-NAG.67 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.15: 8 residues within 4Å: Chain D: R.119, M.339, N.352, T.354 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.5, NAG-NAG-BMA-MAN-MAN-MAN-MAN.5, NAG-NAG-BMA-MAN.14, NAG-NAG-BMA-MAN-MAN-MAN.16 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:R.119 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40: 8 residues within 4Å: Chain L: R.119, M.339, N.352, T.354 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.30, NAG-NAG-BMA-MAN-MAN-MAN-MAN.30, NAG-NAG-BMA-MAN.39, NAG-NAG-BMA-MAN-MAN-MAN.41 1 PLIP interactions: 1 interactions with chain L Hydrogen bonds: L:R.119 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.65: 8 residues within 4Å: Chain T: R.119, M.339, N.352, T.354 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.55, NAG-NAG-BMA-MAN-MAN-MAN-MAN.55, NAG-NAG-BMA-MAN.64, NAG-NAG-BMA-MAN-MAN-MAN.66 1 PLIP interactions: 1 interactions with chain T Hydrogen bonds: T:R.119

3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN.16: 2 residues within 4Å: Chain D: N.358 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.15 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN.41: 2 residues within 4Å: Chain L: N.358 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN.66: 2 residues within 4Å: Chain T: N.358 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.65 No protein-ligand interaction detected (PLIP)

6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.17: 6 residues within 4Å: Chain D: E.321, N.322, K.323, T.324, N.363 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.13 No protein-ligand interaction detected (PLIP) NAG-NAG.19: 2 residues within 4Å: Chain D: N.425 Ligands: NAG-NAG-BMA-MAN.14 No protein-ligand interaction detected (PLIP) NAG-NAG.42: 6 residues within 4Å: Chain L: E.321, N.322, K.323, T.324, N.363 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.38 No protein-ligand interaction detected (PLIP) NAG-NAG.44: 2 residues within 4Å: Chain L: N.425 Ligands: NAG-NAG-BMA-MAN.39 No protein-ligand interaction detected (PLIP) NAG-NAG.67: 6 residues within 4Å: Chain T: E.321, N.322, K.323, T.324, N.363 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.63 No protein-ligand interaction detected (PLIP) NAG-NAG.69: 2 residues within 4Å: Chain T: N.425 Ligands: NAG-NAG-BMA-MAN.64 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN.18: 5 residues within 4Å: Chain D: R.220, N.230, S.259, N.410 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.7 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN.43: 5 residues within 4Å: Chain L: R.220, N.230, S.259, N.410 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.32 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN.68: 5 residues within 4Å: Chain T: R.220, N.230, S.259, N.410 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.57 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN.20: 4 residues within 4Å: Chain H: R.64, D.68, N.70, T.72 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN.45: 4 residues within 4Å: Chain P: R.64, D.68, N.70, T.72 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN.70: 4 residues within 4Å: Chain X: R.64, D.68, N.70, T.72 No protein-ligand interaction detected (PLIP)

15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.21: 2 residues within 4Å: Chain A: N.105, K.106 Ligand excluded by PLIP NAG.22: 4 residues within 4Å: Chain A: N.114, E.119 Chain B: Q.1, Y.32 Ligand excluded by PLIP NAG.23: 1 residues within 4Å: Chain A: N.126 Ligand excluded by PLIP NAG.24: 5 residues within 4Å: Chain D: K.102, D.103, V.104, N.105 Chain F: P.93 Ligand excluded by PLIP NAG.25: 2 residues within 4Å: Chain E: S.7, N.23 Ligand excluded by PLIP NAG.46: 2 residues within 4Å: Chain I: N.105, K.106 Ligand excluded by PLIP NAG.47: 4 residues within 4Å: Chain I: N.114, E.119 Chain J: Q.1, Y.32 Ligand excluded by PLIP NAG.48: 1 residues within 4Å: Chain I: N.126 Ligand excluded by PLIP NAG.49: 5 residues within 4Å: Chain L: K.102, D.103, V.104, N.105 Chain N: P.93 Ligand excluded by PLIP NAG.50: 2 residues within 4Å: Chain M: S.7, N.23 Ligand excluded by PLIP NAG.71: 2 residues within 4Å: Chain Q: N.105, K.106 Ligand excluded by PLIP NAG.72: 4 residues within 4Å: Chain Q: N.114, E.119 Chain R: Q.1, Y.32 Ligand excluded by PLIP NAG.73: 1 residues within 4Å: Chain Q: N.126 Ligand excluded by PLIP NAG.74: 5 residues within 4Å: Chain T: K.102, D.103, V.104, N.105 Chain V: P.93 Ligand excluded by PLIP NAG.75: 2 residues within 4Å: Chain U: S.7, N.23 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stewart-Jones, G.B.E. et al., Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B and G. Cell(Cambridge,Mass.) (2016)

Release Date

2016-04-27

Peptides

JR-FL, GP41 ENV ECTODOMAIN: AIQ
35O22: BJR
35O22: CKS
JR-FL, GP120 ENV ECTODOMAIN: DLT
PGT122: EMU
PGT122: FNV
VRC01: GHOPWX

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

I
B

Q
B

B
D

J
D

R
D

C
E

K
E

S
E

D
G

L
G

T
G

E
H

M
H

U
H

F
L

N
L

V
L

G
U

H
V

O
U

P
V

W
U

X
V

JR-FL, GP41 ENV ECTODOMAIN

35O22

35O22

JR-FL, GP120 ENV ECTODOMAIN

PGT122

PGT122

VRC01

Related Entries With Identical Sequence